Literature DB >> 19273719

Early-life sodium exposure unmasks susceptibility to stroke in hyperlipidemic, hypertensive heterozygous Tg25 rats transgenic for human cholesteryl ester transfer protein.

Julius L Decano1, Jason C Viereck, Ann C McKee, James A Hamilton, Nelson Ruiz-Opazo, Victoria L M Herrera.   

Abstract

BACKGROUND: Early-life risk factor exposure increases aortic atherosclerosis and blood pressure in humans and animal models; however, limited insight has been gained as to end-organ complications. METHODS AND
RESULTS: We investigated the effects of early-life Na exposure (0.23% versus 0.4% NaCl regular rat chow) on vascular disease outcomes using the inbred, transgenic [hCETP](25) Dahl salt-sensitive hypertensive rat model of male-predominant coronary atherosclerosis, Tg25. Rather than the expected increase in coronary heart disease, fetal 0.4% Na exposure (< or =2 g of Na per 2-kcal/d diet) induced adult-onset stroke in both sexes (ANOVA P<0.0001), with earlier stroke onset in Tg25 females. Analysis of later onset of 0.4% Na exposure resulted in decreased stroke risk and later stroke onset despite longer 0.4% Na exposure durations, which indicates increasing risk with earlier onset of 0.4% Na exposure. Histological analysis of stroke-positive rat brains revealed cerebral cortical hemorrhagic infarctions, microhemorrhages, neuronal ischemia, and microvascular injury. Ex vivo MRI of stroke-positive rat brains detected cerebral hemorrhages, microhemorrhages, and ischemia with middle cerebral artery distribution and cerebellar noninvolvement. Ultrasound microimaging detected carotid artery disease. Prestroke analysis detected neuronal ischemia and decreased mass of isolated cerebral but not cerebellar microvessels.
CONCLUSIONS: Early-life Na exposure exacerbated hypertension and unmasked stroke susceptibility, with greater female vulnerability in hypertensive, hyperlipidemic Tg25 rats. The reproducible modeling in stroke-prone Tg25 rats of carotid artery disease, cerebral hemorrhagic infarctions, neuronal ischemia, microhemorrhages, and microvascular alterations suggests a pathogenic spectrum with causal interrelationships. This "mixed-stroke" spectrum could represent paradigms of ischemic-hemorrhagic transformation and/or a microangiopathic basis for the association of ischemic lesions, microhemorrhages, and strokes in humans. Together, the data reveal early-life Na exposure to be a significant modifier of hypertension and stroke disease course and hence a potentially modifiable prevention target that deserves systematic study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273719      PMCID: PMC2825876          DOI: 10.1161/CIRCULATIONAHA.108.833327

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  40 in total

1.  Coexistence of microhemorrhages and acute spontaneous brain hemorrhage: correlation with signs of microangiopathy and clinical data.

Authors:  Montserrat Alemany; Anna Stenborg; Andreas Terent; Pirkko Sonninen; Raili Raininko
Journal:  Radiology       Date:  2006-01       Impact factor: 11.105

2.  Nerve cell injury in the brain of stroke-prone spontaneously hypertensive rats.

Authors:  K Fredriksson; H Kalimo; C Nordborg; B B Johansson; Y Olsson
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

3.  Fetal and placental size and risk of hypertension in adult life.

Authors:  D J Barker; A R Bull; C Osmond; S J Simmonds
Journal:  BMJ       Date:  1990-08-04

4.  Cerebral microangiopathy in stroke-prone spontaneously hypertensive rats. An immunohistochemical and ultrastructural study.

Authors:  K Fredriksson; C Nordborg; H Kalimo; Y Olsson; B B Johansson
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 5.  Myeloperoxidase: friend and foe.

Authors:  Seymour J Klebanoff
Journal:  J Leukoc Biol       Date:  2005-02-02       Impact factor: 4.962

6.  Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study.

Authors:  C Napoli; C K Glass; J L Witztum; R Deutsch; F P D'Armiento; W Palinski
Journal:  Lancet       Date:  1999-10-09       Impact factor: 79.321

7.  Prenatal environmental tobacco smoke exposure promotes adult atherogenesis and mitochondrial damage in apolipoprotein E-/- mice fed a chow diet.

Authors:  Zhen Yang; Cynthia A Knight; Madonna M Mamerow; Kasey Vickers; Arthur Penn; Edward M Postlethwait; Scott W Ballinger
Journal:  Circulation       Date:  2004-11-29       Impact factor: 29.690

Review 8.  Rodent models of focal stroke: size, mechanism, and purpose.

Authors:  S Thomas Carmichael
Journal:  NeuroRx       Date:  2005-07

9.  Cerebral microbleeds are common in ischemic stroke but rare in TIA.

Authors:  D J Werring; L J Coward; N A Losseff; H R Jäger; M M Brown
Journal:  Neurology       Date:  2005-12-27       Impact factor: 9.910

10.  Initiation of hypertension in utero and its amplification throughout life.

Authors:  C M Law; M de Swiet; C Osmond; P M Fayers; D J Barker; A M Cruddas; C H Fall
Journal:  BMJ       Date:  1993-01-02
View more
  9 in total

1.  Prestroke proteomic changes in cerebral microvessels in stroke-prone, transgenic[hCETP]-Hyperlipidemic, Dahl salt-sensitive hypertensive rats.

Authors:  Agnes Bergerat; Julius Decano; Chang-Jiun Wu; Hyungwon Choi; Alexey I Nesvizhskii; Ann Marie Moran; Nelson Ruiz-Opazo; Martin Steffen; Victoria Lm Herrera
Journal:  Mol Med       Date:  2011-04-14       Impact factor: 6.354

2.  Molecular imaging of vasa vasorum neovascularization via DEspR-targeted contrast-enhanced ultrasound micro-imaging in transgenic atherosclerosis rat model.

Authors:  Julius L Decano; Anne Marie Moran; Nelson Ruiz-Opazo; Victoria L M Herrera
Journal:  Mol Imaging Biol       Date:  2011-12       Impact factor: 3.488

Review 3.  From design to the clinic: practical guidelines for translating cardiovascular nanomedicine.

Authors:  Iwona Cicha; Cédric Chauvierre; Isabelle Texier; Claudia Cabella; Josbert M Metselaar; János Szebeni; László Dézsi; Christoph Alexiou; François Rouzet; Gert Storm; Erik Stroes; Donald Bruce; Neil MacRitchie; Pasquale Maffia; Didier Letourneur
Journal:  Cardiovasc Res       Date:  2018-11-01       Impact factor: 10.787

Review 4.  Effect of maternal cardiovascular conditions and risk factors on offspring cardiovascular disease.

Authors:  Wulf Palinski
Journal:  Circulation       Date:  2014-05-20       Impact factor: 29.690

Review 5.  Influence of maternal dysmetabolic conditions during pregnancy on cardiovascular disease.

Authors:  Wulf Palinski; Eric Nicolaides; Antonio Liguori; Claudio Napoli
Journal:  J Cardiovasc Transl Res       Date:  2009-05-29       Impact factor: 4.132

6.  "Rogue" [DEspR+CD11b+] neutrophil subset correlates with severity in spontaneous intracerebral hemorrhage.

Authors:  Victoria L M Herrera; Courtney E Takahashi; Mai Q Nguyen; Julie Z Mosaddeghi; Ridiane Denis; David M Greer; Nelson Ruiz-Opazo
Journal:  Front Neurol       Date:  2022-07-25       Impact factor: 4.086

7.  Compatibility of ingredients of Danshen (Radix Salviae Miltiorrhizae) and Honghua (Flos Carthami) and their protective effects on cerebral ischemia-reperfusion injury in rats.

Authors:  Haoyu Wan; Yuting Yang; Zhiwei Li; Lan Cheng; Zhishan Ding; Haitong Wan; Jiehong Yang; Huifen Zhou
Journal:  Exp Ther Med       Date:  2021-06-08       Impact factor: 2.447

8.  Analysis of CD45- [CD34+/KDR+] endothelial progenitor cells as juvenile protective factors in a rat model of ischemic-hemorrhagic stroke.

Authors:  Julius L Decano; Ann Marie Moran; Nicholas Giordano; Nelson Ruiz-Opazo; Victoria L M Herrera
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

9.  Aortic and carotid arterial stiffness and epigenetic regulator gene expression changes precede blood pressure rise in stroke-prone Dahl salt-sensitive hypertensive rats.

Authors:  Victoria L Herrera; Julius L Decano; Nicholas Giordano; Ann Marie Moran; Nelson Ruiz-Opazo
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.